Fundacao Doutor Amaral Carvalho / Hospital Amaral Carvalho

São Paulo, São Paulo 17210-120

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis

Studies at this site

• A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling